Pfizer Inc

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0000078003
Type: FundHoldings: 21Value: $494.8MLatest: 2025Q1

PFIZER INC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 21 holdings worth $0.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
21
Total Value
494849864
Accession Number
0000078003-25-000118
Form Type
13F-HR
Manager Name
Pfizer
Data Enrichment
100% identified
21 identified0 unidentified

Holdings

21 positions • $494.8M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
BioNTech SE
Shares:3.7M
Value:$333.1M
% of Portfolio:67.3% ($333.1M/$494.8M)
Allogene Therapeutics, Inc.
Shares:22.0M
Value:$32.2M
% of Portfolio:6.5% ($32.2M/$494.8M)
Oric Pharmaceuticals, Inc.
Shares:5.4M
Value:$30.0M
% of Portfolio:6.1% ($30.0M/$494.8M)
ARVINAS, INC.
Shares:3.5M
Value:$24.3M
% of Portfolio:4.9% ($24.3M/$494.8M)
Tourmaline Bio, Inc.
Shares:1.3M
Value:$19.4M
% of Portfolio:3.9% ($19.4M/$494.8M)
Wave Life Sciences Ltd.
Shares:1.9M
Value:$15.2M
% of Portfolio:3.1% ($15.2M/$494.8M)
Biohaven Ltd.
Shares:505.6K
Value:$12.2M
% of Portfolio:2.5% ($12.2M/$494.8M)
Cardiff Oncology, Inc.
Shares:2.4M
Value:$7.6M
% of Portfolio:1.5% ($7.6M/$494.8M)
Caribou Biosciences, Inc.
Shares:4.7M
Value:$4.3M
% of Portfolio:0.9% ($4.3M/$494.8M)
Zura Bio Ltd
Shares:3.0M
Value:$3.8M
% of Portfolio:0.8% ($3.8M/$494.8M)
Celcuity Inc.
Shares:349.4K
Value:$3.5M
% of Portfolio:0.7% ($3.5M/$494.8M)
ESSA Pharma Inc.
Shares:1.7M
Value:$2.6M
% of Portfolio:0.5% ($2.6M/$494.8M)
Spero Therapeutics, Inc.
Shares:2.4M
Value:$1.7M
% of Portfolio:0.3% ($1.7M/$494.8M)
Zentalis Pharmaceuticals, Inc.
Shares:953.8K
Value:$1.5M
% of Portfolio:0.3% ($1.5M/$494.8M)
Pyxis Oncology, Inc.
Shares:1.1M
Value:$1.1M
% of Portfolio:0.2% ($1.1M/$494.8M)
AN2 Therapeutics, Inc.
Shares:715.3K
Value:$972.8K
% of Portfolio:0.2% ($972.8K/$494.8M)
NextCure, Inc.
Shares:1.6M
Value:$755.7K
% of Portfolio:0.2% ($755.7K/$494.8M)
Q32 Bio Inc.
Shares:277.8K
Value:$458.3K
% of Portfolio:0.1% ($458.3K/$494.8M)
Bolt Biotherapeutics, Inc.
Shares:626.1K
Value:$250.4K
% of Portfolio:0.1% ($250.4K/$494.8M)
Senseonics Holdings, Inc.
Shares:43.4K
Value:$28.5K
% of Portfolio:0.0% ($28.5K/$494.8M)